Rhumbline Advisers Nant Health, Inc. Transaction History

Rhumbline Advisers

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$0.42 - $0.78 $7,940 - $14,747	-18,907 Closed	0 $0
Q1 2022 May 12, 2022	SELL	$0.75 - $1.08 $2,299 - $3,311	-3,066 Reduced 13.95%	18,907 $14,000
Q4 2021 Feb 10, 2022	BUY	$0.94 - $1.85 $18 - $37	20 Added 0.09%	21,973 $23,000
Q3 2021 Nov 12, 2021	BUY	$1.61 - $2.41 $2,237 - $3,349	1,390 Added 6.76%	21,953 $35,000
Q2 2021 Aug 05, 2021	SELL	$2.25 - $3.37 $312 - $468	-139 Reduced 0.67%	20,563 $48,000
Q1 2021 May 06, 2021	BUY	$3.0 - $5.1 $1,350 - $2,295	450 Added 2.22%	20,702 $66,000
Q4 2020 Feb 10, 2021	BUY	$1.96 - $3.56 $4,076 - $7,404	2,080 Added 11.45%	20,252 $65,000
Q3 2020 Nov 12, 2020	SELL	$2.1 - $5.99 $9,870 - $28,153	-4,700 Reduced 20.55%	18,172 $43,000
Q2 2020 Aug 13, 2020	BUY	$1.45 - $4.99 $33,164 - $114,131	22,872 New	22,872 $105,000
Q2 2019 Aug 14, 2019	SELL	$0.53 - $0.94 $14,441 - $25,614	-27,249 Closed	0 $0
Q1 2019 May 01, 2019	SELL	$0.52 - $1.33 $65 - $166	-125 Reduced 0.46%	27,249 $25,000
Q4 2018 Jan 31, 2019	BUY	$0.5 - $1.7 $4,120 - $14,008	8,240 Added 43.06%	27,374 $15,000
Q3 2018 Nov 07, 2018	SELL	$1.41 - $3.6 $599 - $1,530	-425 Reduced 2.17%	19,134 $30,000
Q2 2018 Aug 06, 2018	BUY	$3.01 - $3.54 $14,011 - $16,478	4,655 Added 31.23%	19,559 $65,000
Q1 2018 May 02, 2018	SELL	$2.94 - $3.95 $2,866 - $3,851	-975 Reduced 6.14%	14,904 $45,000
Q4 2017 Feb 09, 2018	SELL	$2.92 - $4.97 $292 - $497	-100 Reduced 0.63%	15,879 $48,000
Q3 2017 Nov 06, 2017	BUY	$2.66 - $4.68 $42,504 - $74,781	15,979	15,979 $66,000

Ticker NH
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 115,550,000
Market Cap $48.5M
Description
NantHealth, Inc., together with its subsidiaries, operates as a healthcare IT company in the United States, Canada, and the United Kingdom. It offers Eviti, a software-as-a-service (SaaS) based clinical decision support solution that centralizes clinical content and treatment cost data from Medicare reimbursements and treatment toxicity data; Ev...

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

Stay updated on Rhumbline Advisers with notifications on news.